ロード中...
Erythropoietin Receptor Signaling through STAT3 Is Required for Glioma Stem Cell Maintenance
Recombinant erythropoietin (EPO) is a growth factor used in the treatment of chemotherapy-induced anemia, but recent studies suggest that EPO may accelerate cancer growth. Although several cancers express EPO receptors (EPORs), the mechanism by which EPOR promotes tumor growth remains poorly underst...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2906804/ https://ncbi.nlm.nih.gov/pubmed/20657792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1947601909356352 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|